Xenon Pharmaceuticals (XENE) Short Interest Ratio & Short Volume → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free XENE Stock Alerts $40.58 +0.10 (+0.25%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Xenon Pharmaceuticals Short Interest DataCurrent Short Volume2,790,000 sharesPrevious Short Volume2,620,000 sharesChange Vs. Previous Month+6.49%Dollar Volume Sold Short$113.41 millionShort Interest Ratio / Days to Cover7.8Last Record DateApril 30, 2024Outstanding Shares75,469,000 sharesPercentage of Shares Shorted3.70%Today's Trading Volume295,385 sharesAverage Trading Volume388,618 sharesToday's Volume Vs. Average76% Short Selling Xenon Pharmaceuticals ? Sign up to receive the latest short interest report for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXENE Short Interest Over TimeXENE Days to Cover Over TimeXENE Percentage of Float Shorted Over Time Ad Paradigm PressBiden FINISHED On June 13th?Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered.Click here now to see his shocking evidence. Xenon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,790,000 shares $113.41 million +6.5%N/A7.8 $40.65 4/15/20242,620,000 shares $108.23 million -5.1%N/A7.3 $41.31 3/31/20242,760,000 shares $118.82 million +5.3%N/A7 $43.05 3/15/20242,620,000 shares $115.18 million -3.0%N/A5.7 $43.96 2/29/20242,700,000 shares $127.44 million +6.7%N/A5.3 $47.20 2/15/20242,530,000 shares $123.19 million -10.0%N/A4.2 $48.69 Get the Latest News and Ratings for XENE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,810,000 shares $127.07 million +12.0%N/A4.2 $45.22 1/15/20242,510,000 shares $113.18 million +13.1%N/A3.6 $45.09 12/31/20232,220,000 shares $102.25 million -5.9%N/A3.3 $46.06 12/15/20232,360,000 shares $97.73 million +20.4%N/A3.6 $41.41 11/30/20231,960,000 shares $71.70 million +14.6%N/A3.3 $36.58 11/15/20231,710,000 shares $49.85 million -2.8%N/A3.4 $29.15 10/31/20231,760,000 shares $54.56 million -10.2%N/A4.2 $31.00 10/15/20231,960,000 shares $68.87 million -26.3%N/A5.2 $35.14 9/30/20232,660,000 shares $90.87 million -4.0%N/A7.2 $34.16 9/15/20232,770,000 shares $102.10 million -0.4%N/A8.6 $36.86 8/31/20232,780,000 shares $108.36 million +2.2%N/A8.5 $38.98 8/15/20232,720,000 shares $101.62 million +2.6%N/A7.8 $37.36 7/31/20232,650,000 shares $97.84 million -4.3%N/A7.8 $36.92 7/15/20232,770,000 shares $107.61 million -10.9%N/A7.7 $38.85 6/30/20233,110,000 shares $119.74 million -2.8%N/A8.6 $38.50 6/15/20233,200,000 shares $134.50 million +9.6%N/A8.3 $42.03 5/31/20232,920,000 shares $112.51 million -3.6%N/A7.5 $38.53 5/15/20233,030,000 shares $126.47 million -12.2%N/A7.5 $41.74 4/30/20233,450,000 shares $138.97 million -1.2%N/A8.5 $40.28 4/15/20233,490,000 shares $124.24 million -11.4%N/A9 $35.60 3/31/20233,940,000 shares $141.01 million +7.7%N/A9.8 $35.79 3/15/20233,660,000 shares $124.37 million +16.2%N/A9.3 $33.98 2/28/20233,150,000 shares $124.30 million +2.9%N/A8.1 $39.46 2/15/20233,060,000 shares $118.76 million +1.0%N/A8.3 $38.81 1/31/20233,030,000 shares $118.44 million -16.5%N/A8 $39.09 1/15/20233,630,000 shares $131.41 million +1.4%N/A9.5 $36.20 12/30/20223,580,000 shares $141.16 million -6.3%N/A9.6 $39.43 12/15/20223,820,000 shares $145.81 million +2.4%N/A10.4 $38.17 11/30/20223,730,000 shares $137.56 million +1.4%N/A10.7 $36.88 11/15/20223,680,000 shares $128.03 million +4.8%N/A10.3 $34.79 10/31/20223,510,000 shares $128.36 million +9.0%N/A9 $36.57 10/15/20223,220,000 shares $111.64 million +15.8%N/A8.2 $34.67 9/30/20222,780,000 shares $100.36 million +7.3%N/A6.9 $36.10 9/15/20222,590,000 shares $101.79 million +9.8%N/A5.9 $39.30Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… XENE Short Interest - Frequently Asked Questions What is Xenon Pharmaceuticals' current short interest? Short interest is the volume of Xenon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,790,000 shares of XENE short. Learn More on Xenon Pharmaceuticals' current short interest. What is a good short interest ratio for Xenon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XENE shares currently have a short interest ratio of 8.0. Learn More on Xenon Pharmaceuticals's short interest ratio. Which institutional investors are shorting Xenon Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Xenon Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Xenon Pharmaceuticals' short interest increasing or decreasing? Xenon Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,790,000 shares, an increase of 6.5% from the previous total of 2,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Xenon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Xenon Pharmaceuticals: IDEAYA Biosciences, Inc. (16.17%), Janux Therapeutics, Inc. (9.55%), HUTCHMED (China) Limited (0.26%), Arrowhead Pharmaceuticals, Inc. (7.74%), Amicus Therapeutics, Inc. (9.71%), Prestige Consumer Healthcare Inc. (3.79%), Ultragenyx Pharmaceutical Inc. (5.59%), Axsome Therapeutics, Inc. (16.23%), Biohaven Ltd. (10.91%), Merus (5.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Xenon Pharmaceuticals stock? Short selling XENE is an investing strategy that aims to generate trading profit from Xenon Pharmaceuticals as its price is falling. XENE shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xenon Pharmaceuticals? A short squeeze for Xenon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XENE, which in turn drives the price of the stock up even further. How often is Xenon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XENE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: IDYA Short Interest Data JANX Short Interest Data HCM Short Interest Data ARWR Short Interest Data FOLD Short Interest Data PBH Short Interest Data RARE Short Interest Data AXSM Short Interest Data BHVN Short Interest Data MRUS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XENE) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company